NCT04995523RilvegostomigNSCLCnon-small cell lung cancer
…small cell lung cancer (NSCLC) in a Phase I/II clinical trial ( NCT04995523).1 Rilvegostomig is currently progressing through multiple Phas…
1articles mentioning funders
1funder mentions
1distinct funders extracted
0%of mentions human-reviewed
Active filtersEntity: NCT04995523 ×
NCT04995523
This funder is selected. Its supporting articles are shown below.